Semaglutide for risky alcohol use in Veterans
About this title
Cessation or Reduction of Alcohol Consumption in Veterans: A Randomized Controlled Trial for Alcohol Use Disorder (CRAVE)
Read the official source — NCT07218354Understand this study
Who could participate?
Listed age limits: 18 years to 80 years.
What will I do during this study?
Participants receive a semaglutide or placebo (an inactive comparison treatment) injection once a week for 24 weeks, followed by a four-week safety follow-up. The semaglutide dose starts low and is gradually increased, up to 2.4 mg per week if tolerated. The study team tracks alcohol use using calendar-based interviews.
- Listed locations
- Long Beach and 18 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Participation duration
- 24 weeks of treatment, followed by 4 weeks of safety follow-up
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 622
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 80 Years
- Official registry ID
- NCT07218354
- Official title
Show the full official title
CSP #2041 - Cessation or Reduction of Alcohol Consumption in VEterans: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial to Evaluate the Efficacy and Safety of a GLP-1 Receptor Agonist Semaglutide in U.S. Veterans With Alcohol Use Disorder (CRAVE)
Recruitment & locations
Long Beach · Palo Alto · West Los Angeles
15 more locations
- Orlando
- Decatur
- Hines
- Ann Arbor
- Minneapolis
- Asheville
- Durham
- Cleveland
- Portland
- Philadelphia
- Dallas
- Houston
- Salt Lake City
- Tacoma
- Madison
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including Semaglutide and Placebo.
Who can participate?
Listed age limits: 18 years to 80 years.
Is this study still recruiting?
The registry lists this study as recruiting.
